Recognition and Lysis of Human Melanoma by a CD3+, CD4+, CD8−T-Cell Clone Restricted by HLA-A2

• Published in: Cellular immunology Vol. 172; no. 1; pp. 52 - 59
• Main Authors: Darrow, Timothy L., Abdel-Wahab, Zeinab, Quinn-Allen, Mary Ann, Seigler, Hilliard F.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 25.08.1996
• Subjects: CD3 Complex - immunology; CD4 Antigens - immunology; CD8 Antigens - immunology; Cell Division; Clone Cells; HLA-A2 Antigen - immunology; Humans; Melanoma - immunology; Melanoma - pathology; T-Lymphocytes, Cytotoxic - cytology; T-Lymphocytes, Cytotoxic - immunology; Tumor Cells, Cultured
• ISSN: 0008-8749; 1090-2163
• DOI: 10.1006/cimm.1996.0214

Thein vitrocytotoxic response to human melanoma is characterized by CD3+CD8+T-cells which recognize shared peptide antigens presented in the context of HLA class-I-encoded gene products. We report here studies of a CD3+, CD4+, CD8−, HLA-A2-restricted, melanoma-specific cytotoxic T-cell clone derived by limiting dilution from a T-cell line induced in PBLs from a melanoma patient followingin vitrostimulation with an HLA-A2-matched melanoma cell line. The CD4+cytotoxic T-cell clone is lytic only for melanomas which share the HLA-A2 allele, and the cytotoxicity is blocked by antibody to the T-cell receptor and by antibody to HLA class I. The clone proliferates only following stimulation with HLA-A2-matched melanoma tumor cells. The data suggest that cytotoxic CD4+T-cells may play a significant role in immunity to melanoma, and HLA class-I-restricted recognition of melanoma may not necessarily require the CD8 molecule on the lytic T-cell.